Elanco Animal Health Incorporated (ELAN) financial statements (2022 and earlier)

Company profile

Business Address 2500 INNOVATION WAY
GREENFIELD, IN 46140
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6384535805154956601,391
Cash and cash equivalents6384535805154956601,391
Restricted cash and investments    111111
Receivables1,0281,0821,1741,1321,077833617
Inventory, net of allowances, customer advances and progress billings1,3731,3831,4501,4241,5781,5971,065
Inventory1,3731,3831,4501,4241,5781,5971,065
Other undisclosed current assets237242227273256181107
Total current assets:3,2763,1603,4313,3443,4173,2813,191
Noncurrent Assets
Property, plant and equipment1,0611,0411,0331,2711,3161,243924
Intangible assets, net (including goodwill)11,75912,00711,99412,04812,61212,2205,477
Goodwill6,1726,1916,2396,0166,2256,4353,044
Intangible assets, net (excluding goodwill)5,5875,8165,7556,0326,3875,7862,433
Other noncurrent assets387357375325348493284
Total noncurrent assets:13,20713,40513,40213,64414,27613,9566,685
TOTAL ASSETS:16,48316,56516,83316,98817,69317,2379,876
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities603595630525645496300
Accounts payable418436506411501356243
Employee-related liabilities18515912411414414057
Deferred revenue316316303331295279164
Debt2946155560555555426
Due to related parties    51124
Other liabilities430390502573577532322
Total current liabilities:1,6431,3621,9902,0342,0761,871835
Noncurrent Liabilities
Long-term debt and lease obligation6,0256,2735,5425,5565,5725,5872,030
Long-term debt, excluding current maturities6,0256,2735,5425,5565,5725,5872,030
Liabilities, other than long-term debt1,2771,2481,3211,3911,5681,435358
Deferred income tax liabilities74572676782890082366
Liability, pension and other postretirement and postemployment benefits27130231731634629984
Other liabilities261220237247322313209
Total noncurrent liabilities:7,3027,5216,8636,9477,1417,0222,389
Total liabilities:8,9458,8838,8538,9819,2178,8933,224
Stockholders' equity
Stockholders' equity attributable to parent7,5387,6827,9808,0078,4768,3446,652
Additional paid in capital8,6968,6808,6638,6478,6508,6206,886
Accumulated other comprehensive income (loss)(209)(146)65(102)303(122)(215)
Accumulated deficit(949)(852)(748)(538)(477)(154)(19)
Total stockholders' equity:7,5387,6827,9808,0078,4768,3446,652
TOTAL LIABILITIES AND EQUITY:16,48316,56516,83316,98817,69317,2379,876

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues1,1131,1311,2791,2421,140890586
Cost of revenue(564)(573)(608)(630)(596)(442)(296)
Cost of goods and services sold(512)(502)(551)(569)(596)(442)(296)
Gross profit:549558671612544448290
Operating expenses(670)(688)(907)(692)(818)(724)(391)
Operating loss:(121)(130)(236)(80)(274)(276)(100)
Nonoperating income (expense)3(11)3 1711548
Investment income, nonoperating (27)3   (3)
Interest and debt expense(55)(60)(60)(61)(60)(48)(25)
Loss from continuing operations before equity method investments, income taxes:(173)(201)(293)(141)(318)(209)(77)
Other undisclosed income from continuing operations before income taxes52715761   
Loss from continuing operations before income taxes:(121)(130)(236)(80)(318)(209)(77)
Income tax expense (benefit)24262619(5)7424
Net loss available to common stockholders, diluted:(97)(104)(210)(61)(323)(135)(53)

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(97)(104)(210)(61)(323)(135)(53)
Other comprehensive income (loss)(63)(211)167(405)4259328
Comprehensive income (loss), net of tax, attributable to parent:(160)(315)(43)(466)102(42)(25)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: